Alvotech Holdings S.A
Develops and manufactures affordable biosimilar medicines for global patient access.
ALVO | LU
Overview
Corporate Details
- ISIN(s):
- LU2458332611
- LEI:
- 222100DCZBOWV5DZ8372
- Country:
- Luxembourg
- Address:
- 9, RUE DE BITBOURG, L-1273 LUXEMBOURG
- Website:
- https://www.alvotech.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Alvotech is a global biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines. The company's mission is to improve lives by increasing patient access to high-quality, affordable biologic treatments worldwide. Alvotech operates a vertically integrated platform, managing the entire process from cell line development to fill-and-finish manufacturing. This end-to-end approach provides control, scale, and speed in its development and production processes. For global commercialization, the company forms strategic partnerships with third parties to market and distribute its robust pipeline of biosimilars to patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-24 11:30 |
Regulatory News Service
Markaðsleyfi veitt á Evrópska efnahagssvæðinu fyrir AVT03, hliðstæðu Alvotech v…
|
Icelandic | 8.4 KB | ||
| 2025-11-24 11:30 |
Regulatory News Service
Alvotech Announces Approval of AVT03, a Biosimilar to Prolia® and Xgeva® (denos…
|
English | 13.3 KB | ||
| 2025-11-20 10:00 |
Regulatory News Service
Alvotech og Advanz Pharma fá markaðsleyfi á Evrópska efnahagssvæðinu fyrir Gobi…
|
Icelandic | 7.4 KB | ||
| 2025-11-20 10:00 |
Regulatory News Service
Alvotech and Advanz Pharma Receive Marketing Approval Across the European Econo…
|
English | 13.7 KB | ||
| 2025-11-12 22:40 |
Earnings Release
Alvotech kynnir uppgjör fyrstu níu mánaða ársins 2025 og helstu áfanga í rekstr…
|
Icelandic | 24.6 KB | ||
| 2025-11-12 22:40 |
Earnings Release
Alvotech Reports Results for the First Nine Months of 2025 and Provides a Busin…
|
English | 29.2 KB | ||
| 2025-11-10 10:00 |
Legal Proceedings Report
Alvotech vinnur sigur í mikilvægu dómsmáli um framleiðslu og markaðssetningu AV…
|
Icelandic | 7.9 KB | ||
| 2025-11-10 10:00 |
Legal Proceedings Report
UK High Court Rules in Favor of Alvotech Paving Way for Manufacture and Market …
|
English | 10.3 KB | ||
| 2025-11-06 15:00 |
Regulatory News Service
Alvotech og Advanz Pharma fá markaðsleyfi í Bretlandi fyrir Gobivaz, hliðstæðu …
|
Icelandic | 7.2 KB | ||
| 2025-11-06 15:00 |
Regulatory News Service
Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz®, a Bio…
|
English | 16.4 KB | ||
| 2025-11-04 22:01 |
Report Publication Announcement
Alvotech kynnir afkomu fyrstu níu mánaða ársins og ræðir nýjustu áfanga í rekst…
|
Icelandic | 3.7 KB | ||
| 2025-11-04 22:01 |
Report Publication Announcement
Alvotech Announces Webcast on November 13, 2025 to Report Financial Results for…
|
English | 5.9 KB | ||
| 2025-11-02 23:10 |
Legal Proceedings Report
Alvotech birtir nýjar upplýsingar um stöðu umsóknar um markaðsleyfi fyrir AVT05…
|
Icelandic | 6.4 KB | ||
| 2025-11-02 23:10 |
Regulatory News Service
Alvotech Provides Update on the Status of U.S. Biologics License Application fo…
|
English | 7.6 KB | ||
| 2025-10-22 11:00 |
Board/Management Information
Skipulagsbreytingar á viðskiptasviði Alvotech
|
Icelandic | 6.6 KB |
Automate Your Workflow. Get a real-time feed of all Alvotech Holdings S.A filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Alvotech Holdings S.A
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Alvotech Holdings S.A via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
